• 1
    Lazarow PB, Moser HW. Disorders of peroxisome biogenesis. In: ScriverCR. BeaudetAL. SlyWS. et al. eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989: 14791509.
  • 2
    Hiltunen JK, Filpulla SA, Hayrinen HM, Koivuranta KT, Hakkola EH. Peroxisomal b-oxidation of polyunsaturated fatty acids. Biochimie 1993; 75: 175182.
  • 3
    Osmundsen H, Thomassen MS, Hiltunen JK, Berge RK. Physiological role of peroxisomal beta-oxidation. In: FahimiHD. SiesH. eds. Peroxisomes in biology and medicine. Heidelberg: Springer-Verlag, 1987: 152165.
  • 4
    Reddy JK, Lalwani ND, Dabholkar AS, Reddy MK, Qureshi SA. Increased peroxisomal activity in the liver of vitamin E deficient rats. Biochem Int 1981; 3: 4149.
  • 5
    Neat CE, Thomassen MS, Osmundsen H. Induction of peroxisomal β-oxidation in rat liver by high-fat diets. Biochem J 1980; 186: 369371.
  • 6
    Flatmark T, Nilsson A, Kvannes J, Eikhom TS, Fukami MH, Kryvi H, Christiansen EN. On the mechanism of induction of the enzyme systems for peroxisomal β-oxidation of fatty acids in rat liver by diets rich in partially hydrogenated fish oil. Biochim Biophys Acta 1988; 962: 122130.
  • 7
    Bremer J, Norum KR. Metabolism of very long-chain monounsaturated fatty acids (22:1) and the adaptation to their presence in the diet. J Lipid Res 1982; 23: 243256.
  • 8
    Peristeris P, Clark BD, Gatti S, Faggioni R, Mantovani A, Mengozzi M, Orencole SF. et al. N-acetylcysteine and glutathione as inhibitors of tumor necrosis factor production. Cell Immunol 1992; 140: 390399.
  • 9
    Schreck R, Albermann K, Baeuerle PA. Nuclear factor kB. an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Rad Res Comms 1992; 17: 221237.
  • 10
    Paigen B, Morrow M, Holmes PA, Mitchell D, Williams RA. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987; 68: 231240.
  • 11
    Paigen B, Morrow A, Brandon C, Mitchell D, Holmes P. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis 1985; 57: 6573.
  • 12
    Lazarow PB. Assay of peroxisomal β-oxidation of fatty acids. In: LowensteinJM. ed. Methods in enzymology. Orlando, FL: Academic Press, Inc., 1981: 315319.
  • 13
    Chantrenne H. Effets d'un inhibiteur de la catalase sur la formaion induite de cet enzyme chez la levure. Biochim Biophys Acta 1955; 16: 410417.
  • 14
    Findlay J, Lewy GA, Marsh CA. Inhibition of glycosidases by aldonolactones of corresponding configuration. Biochem J 1958; 69: 467476.
  • 15
    Zar JH. Biostatistical analysis. In: McElroyWD. SwansonCP. eds. Englewood Cliffs: Prentice-Hall, 1974: 151155.
  • 16
    Liao F, Andalibi A, de Beer FC, Fogelman AM, Lusis AJ. Genetic control of inflammatory gene induction and NF-kB-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest 1993; 91: 25722579.
  • 17
    Bautista AP, Meszaros K, Bojita J, Spitzer JJ. Superoxide anion generation in the liver during the early stage of endotoxemia in rats. J Leukoc Biol 1990; 48: 123128.
  • 18
    Baustista AP, Spitzer JJ. Superoxide anion generation by in situ perfused rat liver: effect of in vivo endotoxin. Am J Physiol 1990; 259: G907G912.
  • 19
    Watson J, Kelly K, Largen M, Taylor BA. The genetic mapping of a defective LPS response gene in C3H/HeJ mice. J Immunol 1978; 120: 422424.
  • 20
    Beutler B, Krochin N, Milsark IW, Christina L, Cerami A. Control of cachectin (tumor necrosis factor) synthesis: mechanism of endotoxin resistance. Science 1986; 232: 977980.
  • 21
    Kono Y, Fridovich I. Superoxide radical inhibits catalase. J Biol Chem 1982; 257: 57515754.
  • 22
    Gulati S, Ainol L, Orak J, Singh AK, Singh I. Alterations of peroxisomal function in ischemia-reperfusion injury of rat kidney. Biochim Biophys Acta 1993; 1182: 291298.